Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sumika Fine Chemicals
Osaka, Osaka, Japan
- Ownership
- Private
- Employees
- ~750
- Development stage
- Other
01
Overview
Sumika Fine Chemicals is a prominent Japanese Contract Development and Manufacturing Organization (CDMO) that specializes in the production of Active Pharmaceutical Ingredients (APIs) and intermediates. As a wholly owned subsidiary of Sumitomo Chemical, it operates multiple GMP-compliant facilities and provides advanced chemical synthesis services for a wide variety of small molecule therapies, including cardiology, endocrinology, and gastroenterology treatments.
- Therapeutic areas
- EndocrinologyCardiovascularOphthalmologyGastroenterology
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
Sumitomo PharmaBioNumerik Pharmaceuticals
Beyond the preview
Go deeper on Sumika Fine Chemicals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sumika Fine Chemicals.